Thailand aims to vaccinate up to half of its population against Covid-19 next year according to the director of its National Vaccine Institute, Dr. Nakorn Premsri.
Dr Nakorn Premsri said AstraZeneca, a British-Swedish pharmaceutical company, will produce 200 million doses of its anti-coronavirus vaccine in Thailand next year with the help of Siam Bioscience.
Besides supplying the vaccine to Thailand, AstraZeneca will also support the local mass production of the doses by Siam Bioscience.
The number of doses to be supplied to Thailand was not disclosed, but Prime Minister Prayut Chan-o-cha said last week that the contract was for the purchase of 26 million doses, enough for 13 million people, as each person needs two shots.
Thailand’s Public Health Ministry and the local conglomerate SCG, with its packaging and chemicals divisions, also joined the 200 million doses order stating that most of the doses would head abroad.
“Thailand will secure only 26 million doses. We may ask for more, but it will not be a big part, so maybe more than half of that [200 million] can be exported,” he told VOA.
“It’s in the letter of intent that we made together with Siam Bioscience, AstraZeneca, SCG and Ministry of Public Health that it will be distributed within the ASEAN region,” he added, referring to the 10-member Association of Southeast Asian Nations.
However, Nakorn Premsri told the Financial Time that Thailand was also in talks with other parties, including producers in China, Russia and India, for the possible import of other vaccines.
By today (as of 23rd of December), around 5,762 such cases have been confirmed in Thailand. Over 3,095 patients have recovered and 60 patients have died. An emergency regime will stay in place until January 15, 2021.
Novo Nordisk certified as one of the Best Places to Work in Thailand
Novo Nordisk Thailand certified as one of the Best Places to Work. An exclusive interview with John Dawber, Vice President and general manager who provides insight into what makes the organization an employer of choice
Novo Nordisk Thailand, affiliate of the global healthcare company with more than 90 years of innovation and leadership in diabetes care, has been recently recognized as one of the best companies to work in Thailand.(more…)
Being a small company is a big plus when you’re at ZIM
the ZIM of today is a highly attractive employer, much closer in nature to leading high-tech companies such as Google or Microsoft, than its shipping peers.
Over the last 3 years, ZIM, one of the world’s 11 most profitable shipping companies, has set itself apart from the old-school shipping industry, complex processes, outmoded technology and sluggish response to changes.(more…)
Subscribe via Email
Recovering global trade supports APAC economies but Tourism exposure will temper Thailand’s rebound
The direct contribution of travel and tourism to Thailand's economy was around 10% of GDP before the pandemic, but the...
Thailand Expects 600,000 Tourists from Phuket Sandbox reopening
From 1 July, Phuket will waive quarantine requirements for foreign tourists who have been fully vaccinated against COVID-19 under the...
Thai Government Plans to Increase 2022 Investment Budget by 90 Billion baht ($2.84 bln)
According to the 2022 fiscal budget bill, which has public spending set at 3.1 trillion baht, accounting for 17.9% of...
Fitch Affirms Thailand’s rating at ‘BBB+’ with a Stable Outlook
Fitch forecasts Thailand's tourism-dependent economy will recover only modestly, by 1.8% in 2021 after a sharp 6.1% contraction in 2020.
One-stop SME information portal connecting ASEAN businesses and beyond
The ASEAN Access is a flagship initiative of the ACCMSME, spearheaded by the OSMEP, Thailand and supported by the Federal...